We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+0.25%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$119B
AUM Growth
+$5.64B
Cap. Flow
+$6.41B
Cap. Flow %
5.41%
Top 10 Hldgs %
16.36%
Holding
4,406
New
331
Increased
2,055
Reduced
1,449
Closed
309

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$1.02B
2
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$944M
3
T icon
AT&T
T
+$753M
4
VXF icon
Vanguard Extended Market ETF
VXF
+$553M
5
LIN icon
Linde
LIN
+$379M

Top Sells

Rank Stock Value
1
APC
Anadarko Petroleum
APC
+$331M
2
FDC
First Data Corporation
FDC
+$331M
3
GWR
Genesee & Wyoming Inc.
GWR
+$312M
4
BX icon
Blackstone
BX
+$277M
5
FE icon
FirstEnergy
FE
+$261M

Sector Composition

Rank Sector Weight
1 Healthcare 11.59%
2 Technology 10.75%
3 Financials 9.31%
4 Consumer Discretionary 6.45%
5 Communication Services 5.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PACD
3651
DELISTED
Pacific Drilling S.A. Common Shares
PACD
$253K ﹤0.01%
64,785
+9,061
+16% +$63.8K
CNSL
3652
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$252K ﹤0.01%
52,830
+7,356
+16% +$34.7K
EPOL icon
3653
iShares MSCI Poland ETF
EPOL
$700M
$248K ﹤0.01%
12,000
-4,140
-26% -$90K
FF icon
3654
Future Fuel
FF
$217M
$248K ﹤0.01%
20,763
+1,968
+10% +$22.4K
TRMD icon
3655
TORM
TRMD
$3.1B
$248K ﹤0.01%
31,063
+8,177
+36% +$66.5K
ITCI
3656
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$248K ﹤0.01%
33,203
+11,016
+50% +$106K
SCU
3657
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
$248K ﹤0.01%
+12,709
New +$289K
VRS
3658
DELISTED
Verso Corporation
VRS
$248K ﹤0.01%
20,087
-6,613
-25% -$90.4K
CNBKA
3659
DELISTED
Century Bancorp Inc/Mass
CNBKA
$248K ﹤0.01%
+2,833
New +$240K
CRTO icon
3660
Criteo S.A. Ordinary Shares
CRTO
$1.1B
$247K ﹤0.01%
13,231
-13,137
-50% -$247K
SPH icon
3661
Suburban Propane Partners
SPH
$1.24B
$247K ﹤0.01%
10,466
+157
+2% +$3.71K
PRNB
3662
DELISTED
Principia Biopharma Inc. Common Stock
PRNB
$247K ﹤0.01%
8,786
+241
+3% +$8.84K
PTON icon
3663
Peloton Interactive
PTON
$2.77B
$246K ﹤0.01%
+9,789
New +$248K
YMAB
3664
DELISTED
Y-mAbs Therapeutics
YMAB
$246K ﹤0.01%
+9,415
New +$241K
FTEC icon
3665
Fidelity MSCI Information Technology Index ETF
FTEC
$19.8B
$245K ﹤0.01%
+3,837
New +$244K
FUTY icon
3666
Fidelity MSCI Utilities Index ETF
FUTY
$2.31B
$245K ﹤0.01%
5,760
+617
+12% +$25K
PRMW
3667
DELISTED
Primo Water Corporation
PRMW
$245K ﹤0.01%
19,962
-1,998
-9% -$25.9K
FHLC icon
3668
Fidelity MSCI Health Care Index ETF
FHLC
$3.28B
$244K ﹤0.01%
+5,633
New +$249K
HEZU icon
3669
iShares Currency Hedged MSCI Eurozone ETF
HEZU
$570M
$244K ﹤0.01%
7,876
+905
+13% +$27.2K
RYTM icon
3670
Rhythm Pharmaceuticals
RYTM
$6.81B
$244K ﹤0.01%
11,306
-2,877
-20% -$61.7K
EVC icon
3671
Entravision Communication
EVC
$1.03B
$243K ﹤0.01%
76,473
-47
-0.1% -$148
VGT icon
3672
Vanguard Information Technology ETF
VGT
$139B
$242K ﹤0.01%
8,992
-210,840
-96% -$5.68M
MGNI icon
3673
Magnite
MGNI
$2.76B
$240K ﹤0.01%
27,615
+15,395
+126% +$135K
IMGN
3674
DELISTED
Immunogen Inc
IMGN
$240K ﹤0.01%
99,441
+13,740
+16% +$36.5K
CVLG icon
3675
Covenant Logistics
CVLG
$894M
$239K ﹤0.01%
29,176
-37,242
-56% -$287K
145 146
147
148 149

Similar funds

CSIA
Charles Schwab Investment Advisory San Francisco, California $72.8B AUM 10.03% 1-Year Est. Return
CAN
Cetera Advisor Networks El Segundo, California $20.2B AUM 22.31% 1-Year Est. Return
VAM
Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return
CA
Cetera Advisors Denver, Colorado $12.7B AUM 22.7% 1-Year Est. Return
MNG
Manning & Napier Group Fairport, New York $8.76B AUM 23.27% 1-Year Est. Return
DPAM
Degroof Petercam Asset Management Brussels, Belgium $8.32B AUM
ICG
InterOcean Capital Group Nashville, Tennessee $4.19B AUM 26.29% 1-Year Est. Return
CW
Connectus Wealth Cincinnati, Ohio $3.66B AUM 26.47% 1-Year Est. Return

Credit Suisse's Q3 2019 Portfolio in Review

As of Q3 2019, Credit Suisse held 4,406 positions worth $119B, up 5% from $113B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Credit Suisse deployed $6.41B of net new capital in Q3 2019, opening 331 new positions and adding to 2,055 existing holdings. Its largest new stake was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 11% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Genesee & Wyoming Inc., an estimated $312M trimmed.

  • Credit Suisse's largest Q3 2019 buy was GW Pharmaceuticals Plc American Depositary Shares: 200,027 shares worth $23M.
  • Credit Suisse added most to Allergan plc in Q3 2019, an estimated $1.02B increase.
  • Credit Suisse's biggest Q3 2019 reduction was Genesee & Wyoming Inc., cutting an estimated $312M.
  • Credit Suisse fully exited Anadarko Petroleum in Q3 2019, selling an estimated $331M.
  • Credit Suisse's ten largest holdings make up 16% of its $119B portfolio in Q3 2019.
  • Credit Suisse opened 331 new positions and closed 309 in Q3 2019.
  • Credit Suisse's portfolio value rose 5% quarter-over-quarter to $119B.

Based on Credit Suisse's 13F filing for Q3 2019, filed 12 Nov 2019.